Entries of Rödel, C. on the publication server

Tamaskovics, B.F., Hecht, M., Schubert, P., Kallies, A., Illmer, T., Radke, J., Koelbl, O., Steger, F., Brunner, T.B., Rödel, C., Fleischmann, M., Reinacher-Schick, A., Wingender, L.F., Melchior, P., Klautke, G., Hintzen, U., Gaipl, U.S., Haussmann, J., Budach, W. and Fietkau, R. (2023) 944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial. Annals of Oncology 34, S593. Fulltext not available.

Dapper, H., Belka, C., Bock, F., Budach, V., Budach, W., Christiansen, H., Debus, J., Distel, L., Dunst, J., Eckert, F., Eich, H., Eicheler, W., Engenhart-Cabillic, R., Fietkau, R., Fleischmann, D. F., Frerker, B., Giordano, F. A., Grosu, A. L., Herfarth, K., Hildebrandt, G., Kaul, D., Kölbl, O., Krause, M., Krug, D., Martin, D., Matuschek, C., Medenwald, D., Nicolay, N. H., Niewald, M., Oertel, M., Petersen, C., Pohl, Fabian, Raabe, A., Rödel, C., Rübe, C., Schmalz, C., Schmeel, L. C., Steinmann, D., Stüben, G., Thamm, R., Vordermark, D., Vorwerk, H., Wiegel, T., Zips, D. and Combs, S. E. (2021) Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations. Strahlentherapie und Onkologie 198 (1), pp. 1-11.

Fokas, E., Allgäuer, M., Polat, B., Klautke, G., Grabenbauer, G., Fietkau, R., Kuhnt, T., Staib, L., Brunner, T., Grosu, A. L., Schmiegel, W., Jacobasch, L., Weitz, J., Folprecht, G., Schleska-Lange, A., Grützmann, R., Schwarzbach, M., Paolucci, V., Bechstein, W. O., Friede, T., Ghadimi, M., Hofheinz, R. D. and Rödel, C. (2019) OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial. Radiotherapy and Oncology 133, S257-S258. Fulltext not available.

Hofheinz, R., Fokas, E., Allgäuer, M., Polat, B., Klautke, G., Grabenbauer, G., Fietkau, R., Kuhnt, T., Staib, L., Brunner, T., Grosu, A., Schmiegel, W., Jacobasch, L., Weitz, J., Folprecht, G., Germer, C., Grützmann, R., Schwarzbach, M., Bechstein, W., Friede, T., Ghadimi, M. and Rödel, C. (2019) Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. Annals of Oncology 30, iv129. Fulltext not available.

Liersch, T., Weiss, C., Dellas, K., Hipp, M., Sauer, R., Rödel, C. and Arnold, D. (2011) Effect of pathohistologic complete remission (pCR) rate on the prediction of long-term prognosis following chemoradiotherapy (XRT) with cetuximab (Cet), capecitabine (CAP), and oxaliplatin (OX; Cet-CAPOX) in patients (pts) with locally advanced rectal cancer (LARC). Journal of Clinical Oncology 29 (15_sup), e14035-e14035. Fulltext not available.